Suppr
超能文献

BRAF V600E inhibition in anaplastic thyroid cancer.

作者信息

Rosove Michael H, Peddi Parvin F, Glaspy John A

出版信息

N Engl J Med. 2013 Feb 14;368(7):684-5. doi: 10.1056/NEJMc1215697.

DOI:10.1056/NEJMc1215697

PMID:23406047

Abstract

摘要

相似文献

BRAF V600E inhibition in anaplastic thyroid cancer.

N Engl J Med. 2013 Feb 14;368(7):684-5. doi: 10.1056/NEJMc1215697.

Sustained Response to Vemurafenib in a BRAF-Mutated Anaplastic Thyroid Carcinoma Patient.

Thyroid. 2016 Oct;26(10):1515-1516. doi: 10.1089/thy.2015.0575. Epub 2016 Sep 27.

Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer.

Endocrinology. 2012 Feb;153(2):985-94. doi: 10.1210/en.2011-1519. Epub 2011 Dec 27.

Vemurafenib Active in Iodine-Refractory Thyroid Cancer.

Cancer Discov. 2016 Oct;6(10):OF4. doi: 10.1158/2159-8290.CD-NB2016-105. Epub 2016 Aug 23.

Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer.

Oncotarget. 2016 Mar 29;7(13):17194-211. doi: 10.18632/oncotarget.7839.

Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer.

Br J Cancer. 2018 Nov;119(10):1223-1232. doi: 10.1038/s41416-018-0296-2. Epub 2018 Oct 17.

Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).

Cancer Lett. 2016 Oct 1;380(2):577-585. doi: 10.1016/j.canlet.2015.07.012. Epub 2015 Jul 17.

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.

Clin Lung Cancer. 2016 Mar;17(2):e17-21. doi: 10.1016/j.cllc.2015.12.001. Epub 2015 Dec 18.

BRAF inhibition in refractory hairy-cell leukemia.

N Engl J Med. 2012 May 24;366(21):2038-40. doi: 10.1056/NEJMc1202124.

Tunicamycin induces paraptosis potentiated by inhibition of BRAFV600E in FRO anaplastic thyroid carcinoma cells.

Anticancer Res. 2014 Sep;34(9):4857-68.

引用本文的文献

Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy.

Genes Dis. 2024 Aug 30;12(4):101403. doi: 10.1016/j.gendis.2024.101403. eCollection 2025 Jul.

The road ahead: a brief guide to navigating the 2022 WHO classification of endocrine and neuroendocrine tumours.

J Clin Pathol. 2024 Dec 18;78(1):1-10. doi: 10.1136/jcp-2023-209060.

Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer.

Biomedicines. 2024 Jun 10;12(6):1286. doi: 10.3390/biomedicines12061286.

Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?

Cancers (Basel). 2023 Sep 18;15(18):4621. doi: 10.3390/cancers15184621.

Update on Molecular Diagnostics in Thyroid Pathology: A Review.

Genes (Basel). 2023 Jun 22;14(7):1314. doi: 10.3390/genes14071314.

Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype.

Br J Cancer. 2023 Aug;129(2):249-265. doi: 10.1038/s41416-023-02282-2. Epub 2023 May 17.

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer.

Thyroid Res. 2023 Mar 1;16(1):5. doi: 10.1186/s13044-023-00147-7.

Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management.

Cancers (Basel). 2022 Dec 28;15(1):179. doi: 10.3390/cancers15010179.

A New Way Out of the Predicament of Anaplastic Thyroid Carcinoma From Existing Data Analysis.

Front Endocrinol (Lausanne). 2022 May 26;13:887906. doi: 10.3389/fendo.2022.887906. eCollection 2022.

Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?

Cancer Drug Resist. 2020 Nov 3;3(4):992-1000. doi: 10.20517/cdr.2020.66. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

BRAF V600E inhibition in anaplastic thyroid cancer.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译